$DORM
Dorman Products, Inc.

2016 Q4 Form 10-Q Financial Statement

#000119312516747903 Filed on October 26, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $229.1M $212.8M $210.9M
YoY Change 11.85% 0.88% 6.64%
Cost Of Revenue $136.9M $129.6M $130.1M
YoY Change 7.8% -0.38% 6.74%
Gross Profit $92.20M $83.15M $80.79M
YoY Change 18.51% 2.91% 6.47%
Gross Profit Margin 40.24% 39.07% 38.3%
Selling, General & Admin $45.10M $41.51M $39.55M
YoY Change 3.92% 4.95% 5.75%
% of Gross Profit 48.92% 49.93% 48.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.000M $4.700M $4.100M
YoY Change 11.11% 14.63% 28.12%
% of Gross Profit 5.42% 5.65% 5.07%
Operating Expenses $45.10M $41.51M $39.55M
YoY Change 3.68% 4.95% 5.75%
Operating Profit $47.10M $41.63M $41.24M
YoY Change 37.04% 0.95% 7.18%
Interest Expense -$100.0K $61.00K $48.00K
YoY Change 0.0% 27.08% -17.24%
% of Operating Profit -0.21% 0.15% 0.12%
Other Income/Expense, Net
YoY Change
Pretax Income $47.00M $41.57M $41.19M
YoY Change 37.03% 0.92% 7.22%
Income Tax $18.30M $14.88M $15.13M
% Of Pretax Income 38.94% 35.79% 36.74%
Net Earnings $28.70M $26.70M $26.06M
YoY Change 31.73% 2.44% 6.21%
Net Earnings / Revenue 12.53% 12.55% 12.35%
Basic Earnings Per Share $0.77 $0.73
Diluted Earnings Per Share $831.9K $0.77 $0.73
COMMON SHARES
Basic Shares Outstanding 34.61M shares 34.57M 35.51M shares
Diluted Shares Outstanding 34.67M 35.58M shares

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $149.1M $95.10M $79.30M
YoY Change 89.45% 19.92% 79.41%
Cash & Equivalents $149.1M $95.14M $79.32M
Short-Term Investments
Other Short-Term Assets $3.100M $4.300M $29.90M
YoY Change 34.78% -85.62% 21.05%
Inventory $168.9M $168.2M $195.3M
Prepaid Expenses
Receivables $230.5M $245.0M $199.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $551.6M $512.7M $503.8M
YoY Change 15.25% 1.76% 14.95%
LONG-TERM ASSETS
Property, Plant & Equipment $88.44M $88.38M $86.31M
YoY Change 1.6% 2.41% 6.59%
Goodwill $28.15M
YoY Change 0.0%
Intangibles $1.642M
YoY Change
Long-Term Investments
YoY Change
Other Assets $29.53M $29.57M $19.30M
YoY Change 57.55% 53.26% 557.48%
Total Long-Term Assets $160.2M $155.4M $135.5M
YoY Change 11.83% 14.64% 18.96%
TOTAL ASSETS
Total Short-Term Assets $551.6M $512.7M $503.8M
Total Long-Term Assets $160.2M $155.4M $135.5M
Total Assets $711.8M $668.0M $639.3M
YoY Change 14.46% 4.49% 15.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.63M $52.48M $58.98M
YoY Change 13.54% -11.02% 9.32%
Accrued Expenses $19.32M $22.16M $19.20M
YoY Change -18.25% 15.4% -1.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $103.8M $83.31M $87.03M
YoY Change 5.35% -4.28% 5.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.302M $5.536M $4.706M
YoY Change 19.83% 17.64% -17.35%
Total Long-Term Liabilities $6.302M $5.536M $4.706M
YoY Change 19.83% 17.64% -17.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $103.8M $83.31M $87.03M
Total Long-Term Liabilities $6.302M $5.536M $4.706M
Total Liabilities $110.2M $88.84M $91.74M
YoY Change 6.09% -3.15% 4.25%
SHAREHOLDERS EQUITY
Retained Earnings $557.1M $535.1M $481.9M
YoY Change 17.31% 11.02% 19.97%
Common Stock $44.53M $44.10M $44.12M
YoY Change 3.21% -0.04% 12293.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $601.6M $579.2M $526.1M
YoY Change
Total Liabilities & Shareholders Equity $711.8M $668.0M $639.3M
YoY Change 14.46% 4.49% 15.78%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income $28.70M $26.70M $26.06M
YoY Change 31.73% 2.44% 6.21%
Depreciation, Depletion And Amortization $5.000M $4.700M $4.100M
YoY Change 11.11% 14.63% 28.12%
Cash From Operating Activities $66.00M $19.00M $22.60M
YoY Change 90.75% -15.93% -19.86%
INVESTING ACTIVITIES
Capital Expenditures -$5.200M -$4.800M -$5.500M
YoY Change 0.0% -12.73% -22.54%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$6.200M $0.00
YoY Change -100.0%
Cash From Investing Activities -$5.200M -$11.00M -$5.500M
YoY Change -1.89% 100.0% -22.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.900M -700.0K -5.000M
YoY Change -76.92% -86.0% -83.82%
NET CHANGE
Cash From Operating Activities 66.00M 19.00M 22.60M
Cash From Investing Activities -5.200M -11.00M -5.500M
Cash From Financing Activities -6.900M -700.0K -5.000M
Net Change In Cash 53.90M 7.300M 12.10M
YoY Change -9083.33% -39.67% -223.47%
FREE CASH FLOW
Cash From Operating Activities $66.00M $19.00M $22.60M
Capital Expenditures -$5.200M -$4.800M -$5.500M
Free Cash Flow $71.20M $23.80M $28.10M
YoY Change 78.89% -15.3% -20.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47656000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10970000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34863396 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34863396 shares
CY2015Q4 us-gaap Assets
Assets
621865000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
478633000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
42799000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78659000
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7557000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
203923000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
349000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
63967000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23633000
CY2015Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
29889000
CY2015Q4 us-gaap Inventory Net
InventoryNet
193725000
CY2015Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
78533000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
621865000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5259000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
98570000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
112012000
CY2015Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
3180000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18740000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87046000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
518036000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.86
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
43242 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
34.49
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
474888000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2326000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
40000 shares
CY2015Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
335900000
CY2015Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
86986000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79321000
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8668000
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34613547 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34613547 shares
CY2016Q3 us-gaap Assets
Assets
668005000
CY2016Q3 us-gaap Assets Current
AssetsCurrent
512652000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
43756000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95142000
CY2016Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7581000
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
245006000
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
346000
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
52481000
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22156000
CY2016Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
29814000
CY2016Q3 us-gaap Inventory Net
InventoryNet
168245000
CY2016Q3 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
62445000
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
668005000
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5536000
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
83305000
CY2016Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
102331000
CY2016Q3 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
3469000
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29574000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3737400
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
88384000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.86
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
579164000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.52
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
40000 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
136324 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
44.83
CY2016Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1900000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
535062000
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4259000
CY2016Q3 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
200000
CY2016Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1400000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2000000 shares
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2385320
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
101084 shares
CY2016Q3 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
337300000
CY2016Q3 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
85797000
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34613547 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000 shares
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
31665000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
11739000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.99
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.98
us-gaap Cost Of Goods Sold
CostOfGoodsSold
367866000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2462000
us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
0
us-gaap Sales Revenue Net
SalesRevenueNet
598123000
us-gaap Interest Paid
InterestPaid
211000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2000000
us-gaap Gross Profit
GrossProfit
230257000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
377000
us-gaap Net Income Loss
NetIncomeLoss
70542000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
85000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
111635000
us-gaap Interest Expense
InterestExpense
152000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18534000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6693000
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
-5400000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35535000 shares
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16000
us-gaap Share Based Compensation
ShareBasedCompensation
752000
us-gaap Restricted Stock Expense
RestrictedStockExpense
700000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
7334000
dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
34000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
397000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21727000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4652000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
76000 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
111787000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-7284000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
41709000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3467000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41093000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
57483000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16534000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35611000 shares
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
391900000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
118470000
dei Entity Registrant Name
EntityRegistrantName
Dorman Products, Inc.
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16000 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000868780
dei Document Period End Date
DocumentPeriodEndDate
2016-09-24
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
16483000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
13890000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.24
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.23
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Cost Of Goods Sold
CostOfGoodsSold
384604000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-24000
us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
0
us-gaap Sales Revenue Net
SalesRevenueNet
630507000
us-gaap Interest Paid
InterestPaid
200000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6195000
us-gaap Gross Profit
GrossProfit
245903000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-11646000
us-gaap Net Income Loss
NetIncomeLoss
77348000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1146000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
121373000
us-gaap Interest Expense
InterestExpense
180000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-21085000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
42229000
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
-6300000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
911000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-24480000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4639000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
66000 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
121553000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
44.36
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-4627000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-17938000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
46121000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44025000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
55506000
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2017-12-31
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14890000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
18.94
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
45.63
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34626000 shares
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
366600000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
124350000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
23822 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
240 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y6M
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34560000 shares
dei Trading Symbol
TradingSymbol
DORM
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
117144 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
30.27
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
61084 shares
us-gaap Share Based Compensation
ShareBasedCompensation
1718000
us-gaap Restricted Stock Expense
RestrictedStockExpense
1600000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
17829000
dorm Date Of Plan Approval
DateOfPlanApproval
2009-05-20
dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-109000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
130134000
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
210928000
CY2015Q3 us-gaap Gross Profit
GrossProfit
80794000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
26060000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
41192000
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
129641000
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
212786000
CY2016Q3 us-gaap Gross Profit
GrossProfit
83145000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
26695000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
41572000
CY2015Q3 us-gaap Interest Expense
InterestExpense
48000
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
61000 shares
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
41240000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15132000
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35575000 shares
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39554000
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35514000 shares
CY2016Q3 us-gaap Interest Expense
InterestExpense
61000
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
100000 shares
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
41633000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14877000
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34672000 shares
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41512000
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34572000 shares

Files In Submission

Name View Source Status
0001193125-16-747903-index-headers.html Edgar Link pending
0001193125-16-747903-index.html Edgar Link pending
0001193125-16-747903.txt Edgar Link pending
0001193125-16-747903-xbrl.zip Edgar Link pending
d255652d10q.htm Edgar Link pending
d255652dex311.htm Edgar Link pending
d255652dex312.htm Edgar Link pending
d255652dex32.htm Edgar Link pending
dorm-20160924.xml Edgar Link completed
dorm-20160924.xsd Edgar Link pending
dorm-20160924_cal.xml Edgar Link unprocessable
dorm-20160924_def.xml Edgar Link unprocessable
dorm-20160924_lab.xml Edgar Link unprocessable
dorm-20160924_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending